Aurora Cannabis Inc. (the "Company" or "Aurora") (NASDAQ: ACB) (TSX: ACB), the Canadian-based leading global medical cannabis company, in conjunction with MedReleaf Australia, recently removed the ...

Aurora Cannabis Inc. (TSE:ACB – Get Free Report) has earned an average recommendation of “Moderate Buy” from the five brokerages that are currently covering the company, MarketBeat.com reports. Three ...

While Illinois is taking in a record $490 million in marijuana sales taxes, Ottawa's sales tax revenue is declining.

On Feb. 5, Aurora Cannabis reported its fiscal third-quarter results for the period ended Dec. 31. The cannabis company ...

Aurora has established a significant presence in Denmark through its subsidiary, Aurora Nordic Cannabis A/S, based in Odense.

Anterior insula, medial prefrontal cortex, and dorsolateral prefrontal cortex associated with history of heavy use.

Changes in Opioid Use Outcomes After Passage of Medical Marijuana Laws Jan. 13, 2025 — A new study found no changes in opioid outcomes among the general population with the states' passage of ...

As a leader in the medical cannabis space, Aurora Cannabis is enjoying premium margins. Read why I rate ACB stock a Strong ...

Medical cannabis company Aurora Cannabis (ACB) has surprised markets with a record-breaking third quarter, sending its shares ...

Roth Capital issued their Q1 2026 EPS estimates for shares of Aurora Cannabis in a report released on Thursday, February 6th.

Canopy Growth Q3 sales hit C$74.76 million, surpassing estimates. Medical cannabis revenue rose 16%, while adjusted EBITDA loss improved 61% year-over-year.